Cargando…
Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
Autores principales: | DiNicolantonio, James J, Bhutani, Jaikrit, OKeefe, James H, Crofts, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708305/ https://www.ncbi.nlm.nih.gov/pubmed/29225902 http://dx.doi.org/10.1136/openhrt-2017-000656 |
Ejemplares similares
-
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
The health benefits of vitamin K
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Coenzyme Q10 for the treatment of heart failure: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022) -
Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance
por: DiNicolantonio, James J, et al.
Publicado: (2019)